Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

Biotechnology

Education

Scribe Therapeutics

Benjamin L. Oakes

Director, Laboratory And Facilities Operations

Kristina Oresic Bender

Shilpa Shroff

Ed Sterling II

Michelle Eggers

Sunny Mok

Richard Hector

David Parrot

Vera Switek

Brett T. Staahl

Svetlana Lucas

The Leadership Team at Scribe Therapeutics is responsible for setting the strategic direction of the company, fostering innovation in CRISPR technology, and guiding operational and financial oversight. This team collaborates to drive external partnerships, talent development, and scientific advancements, ensuring the successful engineering and delivery of cutting-edge solutions for genetic disorders.

Leadership Team

Research & Development

Business Operations

Leadership Team

About

Team members

Other teams at Scribe Therapeutics

Research & Development

Business Operations